(1 year, 9 months ago)
Commons ChamberI agree with my hon. Friend that we need to provide researchers and academics with that clarity and certainty. That is exactly why we yesterday extended the guarantee by another three months so that they can be confident, as we have talks with the EU, that there is a system in place.
I welcome the Prime Minister’s creation of this Department and warmly welcome my right hon. Friend to her position as Secretary of State. I also welcome the £370 million that is being invested. In drawing up this framework, what lessons have been learned from the covid-19 pandemic and, in particular, from the success of the vaccines taskforce under Kate Bingham, whose position was, I remind the House, shamefully undermined by the Opposition?
We have taken a great deal of learnings from the operation of the vaccines taskforce, and we have been deploying those learnings, as we can see from the life sciences missions that we have put into process. One of the key learnings relates to the work we do with industry, and also our ability to work much more quickly and to cut through red tape and regulation. My hon. Friend will see from my Department a relentless focus on cutting down that regulation, getting the regulatory framework right and cutting away some of the unnecessary bureaucracy that is holding back our nation from excelling even more.